REPROCELL will be attending BIO-EUROPE from the 25 – 28 October and Clinical Trials Europe 2021 from the 2 - 4 November. Book a meeting with our experts.
Double Staining 2_110SBMC5 A1 NANOG TRA160 5% X10 594 GFP

Clinical Laboratory Services

Over two decades of clinical laboratory experience

Our clinical laboratory services are designed to support your clinical work. Whether you are developing a new drug, cell therapy, or want to preserve your own iPSCs for future therapeutic use, our scientists can help. As pioneers in human fresh tissue testing and stem cell research, we have the experience and expertise to fulfil your clinical goals.


Clinical sample processing

REPROCELL has a proven track record as one of the key sample processing facilities to conduct global multicentric clinical trials. Processing laboratories are vital for clinical trials due to the perishable nature of samples. It is therefore essential to work with partners who can guarantee sample integrity within a given timeframe. With over two decades of experience in human tissue handling, our scientists can support your clinical trials.

Read the Viroclincs press release →


Precision Medicine

Precision medicine promises to improve drug performance by stratifying the patient population. However, these clinical trials are expensive and time-consuming. Using human fresh tissue research, our scientists can stratify your target population at the preclinical stage, before clinical trials begin. By identifying drug respondents at an early stage, we can help you better inform your precision medicine strategies before clinical trial. 

Learn more about our precision medicine services →

A diagram showing how personalized iPSCs can be created from a customer for use in later life-1

Personal iPS

Induced pluripotent stem cell (iPSC) therapies have the potential to treat diseases previously thought incurable. However, tissue collection for iPSC generation can be uncomfortable and invasive. Our Personal iPS service allows the generation of your own, personal stem cells from urine, blood, or dental pulp. By offering non-invasive forms of tissue collection vulnerable donors, such as the very young or elderly, are not excluded from iPSC generation. 

Visit the official Personal iPS website →

Subscribe to clinical updates